echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Active Ingredient News > Study of Nervous System > Lancet Psychiatry: Plasma long-chain fatty acids have a protective effect on schizophrenia

    Lancet Psychiatry: Plasma long-chain fatty acids have a protective effect on schizophrenia

    • Last Update: 2021-11-13
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

    Studies have reported the characteristics of reduced plasma polyunsaturated fatty acid concentrations in patients with schizophrenia and patients with super high risk of psychosis
    .


    Although some studies have reported changes in the concentration of polyunsaturated fatty acids in patients with very high risk of psychosis or patients with first-onset psychosis when they are not taking antipsychotic drugs, it cannot be ruled out that it is caused by poor diet caused by disease or confusion caused by social or other dietary factors.


    Hannah J Jones et al.
    conducted research to determine whether omega-3 and omega-6 fatty acid concentrations are causally related to schizophrenia
    .


    The results of the study were published in the journal Lancet Psychiatry


    Hannah J Jones et al.


    Hannah J Jones et al.
    conducted a two-sample Mendelian randomized study, using the inverse variance-weighted two-sample Mendelian randomization method to assess the exposure-outcome relationship, which used fatty acid concentration and schizophrenia genome-wide association studies ( GWAS s) The result
    .


    The weighted median method, weighted model method and Mendelian randomized Egger regression method were used for sensitivity analysis


    GWAS

    The study found that the concentration of long-chain-3 and long-chain-6 fatty acids was associated with a lower risk of schizophrenia (for example, the negative variance weighted ratio of docosahexaenoic acid [OR] 0.
    83 [95% CI 0.
    75-0.
    92] )
    .

    Concentrations of long-chain-3 and long-chain-6 fatty acids are associated with a lower risk of schizophrenia

    In contrast, there is insufficient evidence that short-chain omega-3 and short-chain omega-6 fatty acids are associated with an increased risk of schizophrenia (inverse variance weighted OR of α-linolenic acid 1.
    07 [95% CI 0.
    98-1.
    18])
    .

    Multivariate Mendelian random analysis evaluates the direct effects of omega-3 fatty acids on schizophrenia and regulates omega-6 fatty acids

    Multivariate Mendelian random analysis evaluates the direct effects of omega-3 fatty acids on schizophrenia and regulates omega-6 fatty acids

    Through sensitivity analysis and FADS single SNP analysis, the results are consistent, indicating that the concentration of long-chain omega-3 and long-chain omega-6 fatty acids is associated with a low risk of schizophrenia (OR 0.
    74 [95% CI 0.
    58-0.
    96], while The concentration of short-chain omega-3 and short-chain omega-6 fatty acids is associated with an increased risk of schizophrenia (for example, OR 1.
    08 [95% CI 1.
    02-1.
    15], α-linolenic acid)
    .

    Long-chain omega-3 and omega-6 long chain fatty acid concentrations and low risk of schizophrenia associated long chain omega-3 and omega-6 long chain fatty acid concentrations and low risk of schizophrenia associated short-chain and short-chain omega-3 Concentrations of omega-6 fatty acids are linked to increased risk of schizophrenia

    Multivariate Mendelian random analysis evaluates the direct effects of omega-3 and omega-6 fatty acids on schizophrenia, and regulates blood lipid measurement

    Multivariate Mendelian random analysis evaluates the direct effects of omega-3 and omega-6 fatty acids on schizophrenia, and regulates blood lipid measurement

    In contrast, estimates from ELOVL2 single SNP analysis are less precise and compatible with the increased risk and protective effects measured by each fatty acid
    .

    Multivariate Mendelian randomization studies have shown that the protective effect of docosahexaenoic acid on schizophrenia still exists after adjusting other lipids, although the evidence is slightly weaker (multivariate inverse variance weighted OR 0.
    84 [95% CI 0.
    71- 1·01])
    .

    The results of this study are consistent with the protective effects of long-chain omega-3 and long-chain omega-6 fatty acids on schizophrenia, indicating that patients with schizophrenia may have difficulty converting short-chain polyunsaturated fatty acids into long-chain polyunsaturated fatty acids
    .


    Further research is needed to determine whether long-chain polyunsaturated fatty acid supplements or a diet rich can help prevent the onset of schizophrenia


    The results of this study are consistent with the protective effects of long-chain omega-3 and long-chain omega-6 fatty acids on schizophrenia, indicating that patients with schizophrenia may have difficulty converting short-chain polyunsaturated fatty acids into long-chain polyunsaturated fatty acids


    Jones HJ, Borges MC, Carnegie R, et al.


    Jones HJ, Borges MC, Carnegie R, et al.
    Associations between plasma fatty acid concentrations and schizophrenia: a two-sample Mendelian randomisation study [published online ahead of print, 2021 Nov 1].
    Lancet Psychiatry.
    2021;S2215-0366(21 )00286-8.
    doi:10.
    1016/S2215-0366(21)00286-8 Jones HJ, Borges MC, Carnegie R, et al.
    Associations between plasma fatty acid concentrations and schizophrenia: a two-sample Mendelian randomisation study [published online ahead .
    of print, 2021 Nov 1] Lancet Psychiatry 2021; S2215-0366 (21) 00286-8 doi:.
    .
    10.
    1016 / S2215-0366 (21) 00286-8 in this message
    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.